Decline In U.S. Medical Funding Is Compromising Future Innovation, Study Says
This article was originally published in The Gray Sheet
Executive Summary
A study in the Journal of American Medical Association says that the U.S. contribution to global biomedical research funding is on the decline, which could have big implications for domestic innovation.
You may also be interested in...
Request For Predictable NIH Funding Growth Met By Spending Caps
The best way to accelerate medical cures, National Institutes of Health Director Francis Collins tells the congressional 21st Century Cures coalition, is to assure that NIH researchers are supplied with a steady, predictable source of grant funding.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.